ONTOLOGY REPORT - ANNOTATIONS
| Term: | maternal process involved in female pregnancy |
|
| Accession: | GO:0060135
|
browse the term
|
| Definition: | A reproductive process occurring in the mother that allows an embryo or fetus to develop within it. |
|
|
maternal process involved in female pregnancy
|
| G |
Adcy7 |
adenylate cyclase 7 |
|
|
IEP |
19 |
20,051,639 |
20,073,861 |
RGD:2316040 |
RGD |
| G |
Agrp |
agouti related protein homolog (mouse) |
|
|
IEP |
19 |
35,386,682 |
35,388,274 |
RGD:6480202 |
RGD |
| G |
Akap5 |
A kinase (PRKA) anchor protein 5 |
|
|
IEP |
6 |
98,923,105 |
98,928,505 |
RGD:2313252 |
RGD |
| G |
Angpt2 |
angiopoietin 2 |
|
|
IEP |
16 |
75,891,757 |
75,942,255 |
RGD:2314217 |
RGD |
| G |
Arg1 |
arginase, liver |
|
|
IEP |
1 |
20,998,894 |
21,011,275 |
RGD:4143426 |
RGD |
| G |
Arg2 |
arginase type II |
|
|
IEP |
6 |
101,901,653 |
101,928,282 |
RGD:4143426 |
RGD |
| G |
Cbs |
cystathionine beta synthase |
|
|
ISO |
20 |
10,047,478 |
10,075,520 |
RGD:1624291 |
RGD |
| G |
Cbs |
cystathionine beta synthase |
|
|
IEA |
20 |
10,047,478 |
10,075,520 |
RGD:1600115 |
ENSEMBL |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
|
IEP |
5 |
50,427,173 |
50,445,471 |
RGD:2316191 |
RGD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
|
IEP |
8 |
61,793,976 |
61,805,308 |
RGD:4833999 |
RGD |
| G |
Dsg1 |
desmoglein 1 |
|
|
IEP |
18 |
12,127,180 |
12,156,469 |
RGD:1581662 |
RGD |
| G |
Dsg2 |
desmoglein 2 |
|
|
IEP |
18 |
12,306,321 |
12,366,719 |
RGD:1581662 |
RGD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
|
IEP |
6 |
96,419,024 |
96,463,891 |
RGD:5147883 |
RGD |
| G |
Hmx3 |
H6 family homeobox 3 |
|
|
ISO |
1 |
191,111,769 |
191,113,733 |
RGD:1624291 |
RGD |
| G |
Hmx3 |
H6 family homeobox 3 |
|
|
IEA |
1 |
191,111,769 |
191,113,733 |
RGD:1600115 |
ENSEMBL |
| G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
|
|
IEP |
2 |
193,500,916 |
193,507,633 |
RGD:4889524 |
RGD |
| G |
Ifi27 |
interferon, alpha-inducible protein 27 |
|
|
IEP |
6 |
127,725,194 |
127,731,665 |
RGD:68731 |
RGD |
| G |
Ihh |
Indian hedgehog |
|
|
IEP |
9 |
74,287,115 |
74,293,332 |
RGD:2306316 |
RGD |
| G |
Itga3 |
integrin, alpha 3 |
|
|
IEP |
10 |
83,728,710 |
83,759,576 |
RGD:2325260 |
RGD |
| G |
Itgb1 |
integrin, beta 1 |
|
|
IEP |
19 |
58,600,095 |
58,647,531 |
RGD:2325260 |
RGD |
| G |
Kpna6 |
karyopherin alpha 6 (importin alpha 7) |
|
|
ISO |
5 |
148,783,562 |
148,793,599 |
RGD:1624291 |
RGD |
| G |
Lif |
leukemia inhibitory factor |
|
|
ISO |
14 |
84,887,856 |
84,890,630 |
RGD:1624291 |
RGD |
| G |
Men1 |
multiple endocrine neoplasia I |
|
|
ISO |
1 |
209,114,987 |
209,120,837 |
RGD:1624291 |
RGD |
| G |
Npff |
neuropeptide FF-amide peptide precursor |
|
|
IEP |
|
|
|
RGD:1299340 |
RGD |
| G |
Pam |
peptidylglycine alpha-amidating monooxygenase |
|
|
IEP |
9 |
96,893,071 |
97,047,523 |
RGD:2302426 |
RGD |
| G |
Pla2g6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
|
|
IEP |
7 |
117,266,784 |
117,307,172 |
RGD:6482751 |
RGD |
| G |
Ppat |
phosphoribosyl pyrophosphate amidotransferase |
|
|
IEP |
14 |
33,509,364 |
33,543,743 |
RGD:1599204 |
RGD |
| G |
Prl8a2 |
prolactin family 8, subfamily a, member 2 |
|
|
ISO |
17 |
44,202,721 |
44,212,845 |
RGD:1624291 |
RGD |
| G |
Prl8a2 |
prolactin family 8, subfamily a, member 2 |
|
|
IEA |
17 |
44,202,721 |
44,212,845 |
RGD:1600115 |
ENSEMBL |
| G |
Ube2a |
ubiquitin-conjugating enzyme E2A |
|
|
ISO |
X |
7,981,683 |
7,992,372 |
RGD:1624291 |
RGD |
| G |
Ube2a |
ubiquitin-conjugating enzyme E2A |
|
|
IEA |
X |
7,981,683 |
7,992,372 |
RGD:1600115 |
ENSEMBL |
decidualization
|
| G |
Bsg |
basigin (Ok blood group) |
|
|
IEP |
7 |
11,507,914 |
11,515,132 |
RGD:2289056 |
RGD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
|
ISO |
1 |
12,721,500 |
12,723,943 |
RGD:1624291 |
RGD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
|
IEA |
1 |
12,721,500 |
12,723,943 |
RGD:1600115 |
ENSEMBL |
| G |
Ctsl1 |
cathepsin L1 |
|
|
IEP |
17 |
6,288,013 |
6,294,174 |
RGD:2315602 |
RGD |
| G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Dedd |
death effector domain-containing |
|
|
ISO |
13 |
87,238,315 |
87,241,703 |
RGD:1624291 |
RGD |
| G |
Dedd |
death effector domain-containing |
|
|
IEA |
13 |
87,238,315 |
87,241,703 |
RGD:1600115 |
ENSEMBL |
| G |
Epor |
erythropoietin receptor |
|
|
ISO |
8 |
21,061,310 |
21,065,886 |
RGD:1624291 |
RGD |
| G |
Epor |
erythropoietin receptor |
|
|
IEA |
8 |
21,061,310 |
21,065,886 |
RGD:1600115 |
ENSEMBL |
| G |
Ghrl |
ghrelin/obestatin prepropeptide |
|
|
ISO |
4 |
149,622,566 |
149,628,111 |
RGD:1624291 |
RGD |
| G |
Ghrl |
ghrelin/obestatin prepropeptide |
|
|
ISS |
4 |
149,622,566 |
149,628,111 |
RGD:1600115 |
UniProtKB |
| G |
Ghsr |
growth hormone secretagogue receptor |
|
|
ISO |
2 |
113,269,623 |
113,272,999 |
RGD:1624291 |
RGD |
| G |
Ghsr |
growth hormone secretagogue receptor |
|
|
ISS |
2 |
113,269,623 |
113,272,999 |
RGD:1600115 |
UniProtKB |
| G |
Junb |
jun B proto-oncogene |
|
|
ISO |
19 |
24,831,536 |
24,833,320 |
RGD:1624291 |
RGD |
| G |
Junb |
jun B proto-oncogene |
|
|
IEA |
19 |
24,831,536 |
24,833,320 |
RGD:1600115 |
ENSEMBL |
| G |
Lif |
leukemia inhibitory factor |
|
|
ISO |
14 |
84,887,856 |
84,890,630 |
RGD:1624291 |
RGD |
| G |
Lif |
leukemia inhibitory factor |
|
|
IEA |
14 |
84,887,856 |
84,890,630 |
RGD:1600115 |
ENSEMBL |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
|
IMP |
13 |
64,135,729 |
64,280,815 |
RGD:1642479 |
RGD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
|
IEP |
20 |
6,479,108 |
6,544,255 |
RGD:2324898 |
RGD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
IMP |
13 |
64,427,288 |
64,432,978 |
RGD:2300266 |
RGD |
| G |
Sfrp4 |
secreted frizzled-related protein 4 |
|
|
IEP |
17 |
53,121,425 |
53,131,507 |
RGD:633927 |
RGD |
| G |
Stc1 |
stanniocalcin 1 |
|
|
IEP |
15 |
49,566,885 |
49,577,539 |
RGD:2324698 |
RGD |
| G |
Stc2 |
stanniocalcin 2 |
|
|
IEP |
10 |
16,514,603 |
16,524,369 |
RGD:2324698 |
RGD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
|
ISO |
7 |
136,567,614 |
136,617,280 |
RGD:1624291 |
RGD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
|
IEA |
7 |
136,567,614 |
136,617,280 |
RGD:1600115 |
ENSEMBL |
| G |
Vim |
vimentin |
|
|
IEP |
17 |
87,847,280 |
87,855,763 |
RGD:6480445 |
RGD |
mammary gland branching involved in pregnancy
|
| G |
Esr1 |
estrogen receptor 1 |
|
|
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:1624291 |
RGD |
| G |
Esr1 |
estrogen receptor 1 |
|
|
IEA |
1 |
35,523,680 |
35,759,891 |
RGD:1600115 |
ENSEMBL |
| G |
Med1 |
mediator complex subunit 1 |
|
|
ISO |
10 |
86,917,525 |
86,959,080 |
RGD:1624291 |
RGD |
| G |
Med1 |
mediator complex subunit 1 |
|
|
IEA |
10 |
86,917,525 |
86,959,080 |
RGD:1600115 |
ENSEMBL |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
|
ISO |
7 |
136,567,614 |
136,617,280 |
RGD:1624291 |
RGD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
|
IEA |
7 |
136,567,614 |
136,617,280 |
RGD:1600115 |
ENSEMBL |
maternal placenta development
|
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:1624291 |
RGD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
IEA |
6 |
137,640,482 |
137,657,552 |
RGD:1600115 |
ENSEMBL |
| G |
Dazap1 |
DAZ associated protein 1 |
|
|
ISO |
7 |
10,935,537 |
10,956,289 |
RGD:1624291 |
RGD |
| G |
Nodal |
nodal growth differentiation factor |
|
|
ISO |
20 |
29,546,982 |
29,555,419 |
RGD:1624291 |
RGD |
| G |
Nr2f2 |
nuclear receptor subfamily 2, group F, member 2 |
|
|
IEA |
1 |
125,280,974 |
125,286,929 |
RGD:1600115 |
ENSEMBL |
| G |
Nr2f2 |
nuclear receptor subfamily 2, group F, member 2 |
|
|
ISO |
1 |
125,280,974 |
125,286,929 |
RGD:1624291 |
RGD |
| G |
Prdm1 |
PR domain containing 1, with ZNF domain |
|
|
ISO |
20 |
48,438,224 |
48,459,848 |
RGD:1624291 |
RGD |
| G |
Prdm1 |
PR domain containing 1, with ZNF domain |
|
|
IEA |
20 |
48,438,224 |
48,459,848 |
RGD:1600115 |
ENSEMBL |
| G |
Prdx3 |
peroxiredoxin 3 |
|
|
ISO |
1 |
267,468,371 |
267,481,273 |
RGD:1624291 |
RGD |
| G |
Prdx3 |
peroxiredoxin 3 |
|
|
IEA |
1 |
267,468,371 |
267,481,273 |
RGD:1600115 |
ENSEMBL |
| G |
Rxra |
retinoid X receptor alpha |
|
|
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:1624291 |
RGD |
| G |
Rxra |
retinoid X receptor alpha |
|
|
IEA |
3 |
6,605,782 |
6,689,224 |
RGD:1600115 |
ENSEMBL |
| G |
Rxrb |
retinoid X receptor beta |
|
|
ISO |
20 |
4,954,336 |
4,960,880 |
RGD:1624291 |
RGD |
| G |
Rxrb |
retinoid X receptor beta |
|
|
IEA |
20 |
4,954,336 |
4,960,880 |
RGD:1600115 |
ENSEMBL |
| G |
Stox2 |
storkhead box 2 |
|
|
ISS |
16 |
48,197,064 |
48,305,632 |
RGD:1600115 |
UniProtKB |
| G |
Stox2 |
storkhead box 2 |
|
|
ISO |
16 |
48,197,064 |
48,305,632 |
RGD:1624291 |
RGD |
| G |
Tmed2 |
transmembrane emp24 domain trafficking protein 2 |
|
|
IEA |
12 |
33,165,291 |
33,174,326 |
RGD:1600115 |
ENSEMBL |
tertiary branching involved in mammary gland duct morphogenesis
|
| G |
Ar |
androgen receptor |
|
|
ISO |
X |
85,949,507 |
86,119,199 |
RGD:1624291 |
RGD |
| G |
Ar |
androgen receptor |
|
|
IEA |
X |
85,949,507 |
86,119,199 |
RGD:1600115 |
ENSEMBL |
| G |
Pgr |
progesterone receptor |
|
|
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:1624291 |
RGD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
|
ISO |
5 |
156,064,371 |
156,083,198 |
RGD:1624291 |
RGD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
|
IEA |
5 |
156,064,371 |
156,083,198 |
RGD:1600115 |
ENSEMBL |
Term paths to the root
|